Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Towards Personalized Medicine for Chronic Liver Disease"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: closed (25 March 2023) | Viewed by 4619
Special Issue Editors
Interests: fatty liver disease; machine learning; deep learning
Interests: liver cirrhosis; liver fibrosis; portal hypertension
Special Issue Information
Personalized medicine is a dynamic and rapidly developing approach in clinical practice that involves using innovative technologies to make decisions in the screening, prevention, diagnosis, and treatment of disease. Chronic liver disease is a progressive deterioration of hepatic functions and a continuous process of inflammation, destruction, and regeneration of liver parenchyma, resulting in fibrosis and cirrhosis. The spectrum of etiologies encompasses metabolic disorders, viral infection, toxins, alcohol abuse, and genetic and autoimmune diseases.
The Journal of Personalized Medicine aims to publish a collection of articles exploring recent findings and progress in personalized medicine for chronic liver disease. We will consider original research, systematic reviews, and analyses that report both experimental and clinical studies on integrating precision medicine in the management of chronic liver disease.
Dr. Jinzhou Zhu
Dr. Feng Zhang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- artificial intelligence
- deep learning
- fatty liver disease
- liver cancer
- machine learning
- personalized medicine
- portal hypertension